FIFilingIndexScreener · The Ledger
🔔 Save search
More filtersthe deep cuts
Valuation▼
P/SAny
FCF yieldAny
EV / EBITDAAny
Profitability▼
Gross marginAny
Net marginAny
Growth▼
Rev growthAny
Balance sheet▼
Debt / EquityAny
Dividend▼
Dividend yieldAny
Listing▼
Exchange
Country
Filter
50 of 3,901
Sort
01
JNJJOHNSON & JOHNSON🔥
Healthcare · Pharmaceuticals
$579.83B-1.8%
P/E 27.6·P/S 6.0·Mgn 21.8%·ROE 32.9%·FCF 3.4%
F 4
02
AZNASTRAZENECA PLC🔥
Healthcare · Pharmaceuticals
$277.22B-0.7%
P/E 46.5·P/S 6.1·Mgn 13.0%·ROE 21.0%·FCF 4.2%
—
03
BIIBBIOGEN INC.
Healthcare · Biotechnology
$29.53B-0.3%
P/E 21.5·P/S 3.0·Mgn 13.8%·ROE 7.1%·FCF 6.9%
F 5
13D
04
JAZZJazz Pharmaceuticals plc
Healthcare · Pharmaceuticals
$14.48B+1.4%
P/E 25.9·P/S 3.6·Mgn 13.8%·ROE -8.2%·FCF 9.0%
—
Red 8-K
05
EXELEXELIXIS, INC.
Healthcare · Biotechnology
$13.35B+0.2%
P/E 25.6·P/S 6.2·Mgn 24.0%·ROE 36.2%·FCF 6.6%
F 6
Red 8-K
06
SMMTSummit Therapeutics Inc.
Healthcare · Pharmaceuticals
$10.87B+1.8%
P/E —·P/S —·Mgn —·ROE -163.9%·FCF —
—
07
HALOHALOZYME THERAPEUTICS, INC.
Healthcare · Biotechnology
$8.24B+1.4%
P/E 23.6·P/S 5.5·Mgn 23.1%·ROE 649.2%·FCF 7.8%
F 5
Red 8-K
08
PTGXProtagonist Therapeutics, Inc
Healthcare · Pharmaceuticals
$7.06B+0.8%
P/E —·P/S 95.3·Mgn -154.9%·ROE -21.2%·FCF 0.8%
—
Red 8-K
09
SYRESpyre Therapeutics, Inc.
Healthcare · Pharmaceuticals
$7.02B-1.5%
P/E —·P/S —·Mgn —·ROE -21.7%·FCF —
—
13DRed 8-K
10
SRRKScholar Rock Holding Corp
Healthcare · Biotechnology
$5.29B+0.1%
P/E —·P/S —·Mgn —·ROE -154.0%·FCF -5.7%
—
11
CAICaris Life Sciences, Inc.
Healthcare · Healthcare Services
$5.08B-2.7%
P/E 149.5·P/S 5.6·Mgn 3.7%·ROE -11.8%·FCF 1.3%
—
12
ERASErasca, Inc.
Healthcare · Pharmaceuticals
$4.37B+0.2%
P/E —·P/S —·Mgn —·ROE -38.3%·FCF —
—
13
KNSAKiniksa Pharmaceuticals International, plc
Healthcare · Pharmaceuticals
$3.99B+2.5%
P/E 54.6·P/S 5.3·Mgn 9.7%·ROE 10.4%·FCF 3.4%
F 7
13DRed 8-K
14
DNLIDenali Therapeutics Inc.
Healthcare · Biotechnology
$3.44B-0.7%
P/E —·P/S —·Mgn —·ROE -50.6%·FCF -12.3%
—
15
CLDXCelldex Therapeutics, Inc.
Healthcare · Diagnostics & Tools
$2.45B-0.6%
P/E —·P/S 1588.6·Mgn -16748.0%·ROE -49.1%·FCF -8.7%
F 1
Red 8-K
16
KODKodiak Sciences Inc.
Healthcare · Biotechnology
$2.13B+3.2%
P/E —·P/S —·Mgn —·ROE -146.1%·FCF —
—
17
ZLABZai Lab Ltd
Healthcare · Pharmaceuticals
$1.92B+3.2%
P/E —·P/S 4.2·Mgn -39.3%·ROE -24.5%·FCF -8.3%
F 3
Red 8-K
18
VRDNViridian Therapeutics, Inc.DE
Healthcare · Pharmaceuticals
$1.81B-2.2%
P/E —·P/S 25.5·Mgn -483.6%·ROE -47.4%·FCF -15.3%
—
13D
19
BHVNBiohaven Ltd.⚡
Healthcare · Pharmaceuticals
$1.70B-0.5%
P/E —·P/S 2.0·Mgn -108.3%·ROE -1418.8%·FCF —
—
20
ZYMEZymeworks Inc.
Healthcare · Pharmaceuticals
$1.68B+8.5%
P/E —·P/S 20.7·Mgn -126.3%·ROE -30.2%·FCF -2.1%
—
21
BCAXBicara Therapeutics Inc.
Healthcare · Pharmaceuticals
$1.43B+1.2%
P/E —·P/S —·Mgn —·ROE -34.4%·FCF —
—
22
AVBPArriVent BioPharma, Inc.
Healthcare · Pharmaceuticals
$1.42B+1.1%
P/E —·P/S —·Mgn —·ROE -54.1%·FCF —
—
23
COAGHemab Therapeutics Holdings, Inc.
Healthcare · Biotechnology
$1.17B0.0%
P/E —·P/S —·Mgn —·ROE —·FCF —
—
13DRed 8-K
24
XNCRXencor Inc
Healthcare · Pharmaceuticals
$914M+3.2%
P/E —·P/S 9.4·Mgn -177.1%·ROE -14.5%·FCF -15.1%
—
Red 8-K
25
JANXJanux Therapeutics, Inc.
Healthcare · Pharmaceuticals
$827M+0.2%
P/E —·P/S 60.2·Mgn -833.6%·ROE -11.9%·FCF -10.1%
—
Red 8-K
26
AVTXAvalo Therapeutics, Inc.
Healthcare · Pharmaceuticals
$776M-4.2%
P/E —·P/S —·Mgn —·ROE -94.2%·FCF —
—
Dilut.Red 8-K
27
ALLOAllogene Therapeutics, Inc.
Healthcare · Biotechnology
$656M-6.3%
P/E —·P/S —·Mgn —·ROE -65.3%·FCF -22.8%
—
Red 8-K
28
CTMXCytomX Therapeutics, Inc.
Healthcare · Pharmaceuticals
$655M+0.3%
P/E —·P/S 18.4·Mgn -166.4%·ROE -17.5%·FCF -11.6%
—
Red 8-K
29
CLYMClimb Bio, Inc.
Healthcare · Pharmaceuticals
$655M-2.4%
P/E —·P/S —·Mgn —·ROE -37.3%·FCF —
—
13DDilut.Red 8-K
30
ACRSAclaris Therapeutics, Inc.
Healthcare · Pharmaceuticals
$603M+5.4%
P/E —·P/S 72.1·Mgn -832.6%·ROE -63.0%·FCF -7.8%
F 2
31
CBIOCRESCENT BIOPHARMA, INC.
Healthcare · Pharmaceuticals
$494M0.0%
P/E —·P/S 41.6·Mgn -782.5%·ROE -75.8%·FCF -14.7%
—
32
CABACabaletta Bio, Inc.
Healthcare · Biotechnology
$491M0.0%
P/E —·P/S —·Mgn —·ROE -149.8%·FCF —
—
33
ARVNARVINAS, INC.
Healthcare · Pharmaceuticals
$489M+0.2%
P/E —·P/S 6.2·Mgn -467.9%·ROE -18.6%·FCF -56.4%
—
Red 8-K
34
STROSUTRO BIOPHARMA, INC.
Healthcare · Biotechnology
$477M-0.5%
P/E —·P/S 4.8·Mgn -154.2%·ROE —·FCF —
—
35
STTKShattuck Labs, Inc.
Healthcare · Pharmaceuticals
$472M+1.3%
P/E —·P/S 471.8·Mgn -4987.4%·ROE -59.2%·FCF -8.5%
—
13DRed 8-K
36
CCCCC4 Therapeutics, Inc.
Healthcare · Biotechnology
$431M+7.4%
P/E —·P/S 12.0·Mgn -292.1%·ROE -40.9%·FCF -23.0%
—
Red 8-K
37
CMPXCompass Therapeutics, Inc.
Healthcare · Biotechnology
$366M+1.4%
P/E —·P/S —·Mgn —·ROE -33.8%·FCF -13.4%
—
38
GLSIGreenwich LifeSciences, Inc.
Healthcare · Pharmaceuticals
$353M+0.9%
P/E —·P/S —·Mgn —·ROE -5480.5%·FCF —
—
39
ZURAZura Bio Ltd
Healthcare · Biotechnology
$351M+4.8%
P/E —·P/S —·Mgn —·ROE -67.6%·FCF —
—
Red 8-K
40
LYELLyell Immunopharma, Inc.
Healthcare · Pharmaceuticals
$315M+10.2%
P/E —·P/S —·Mgn —·ROE -110.6%·FCF -47.9%
—
41
MGNXMACROGENICS INC
Healthcare · Pharmaceuticals
$252M-4.9%
P/E —·P/S 1.6·Mgn -44.8%·ROE -134.2%·FCF -33.0%
F 3
42
CHRSCoherus Oncology, Inc.
Healthcare · Biotechnology
$216M-3.5%
P/E —·P/S 0.1·Mgn -0.5%·ROE 275.4%·FCF —
F 6
Red 8-K
43
WHWKWhitehawk Therapeutics, Inc.
Healthcare · Pharmaceuticals
$206M+3.9%
P/E —·P/S 28.8·Mgn -288.3%·ROE -15.1%·FCF -47.6%
F 4
13DDilut.
44
CGENCOMPUGEN LTD
Healthcare · Biotechnology
$193M-0.9%
P/E —·P/S —·Mgn —·ROE 34.4%·FCF 16.2%
F 7
45
CRBUCaribou Biosciences, Inc.
Healthcare · Biotechnology
$158M-0.6%
P/E —·P/S 14.2·Mgn -1327.4%·ROE -121.2%·FCF -71.0%
—
46
AGENAGENUS INC
Healthcare · Biotechnology
$137M-2.9%
P/E 2.2·P/S 1.1·Mgn 50.5%·ROE —·FCF -56.2%
F 4
Red 8-K
47
KLRSKalaris Therapeutics, Inc.
Healthcare · Biotechnology
$103M-3.4%
P/E —·P/S —·Mgn —·ROE —·FCF -19.9%
—
13DRed 8-K
48
IBIOiBio, Inc.
Healthcare · Pharmaceuticals
$84M+1.2%
P/E —·P/S —·Mgn —·ROE -123.5%·FCF -18.2%
—
Red 8-K
49
INKTMiNK Therapeutics, Inc.
Healthcare · Biotechnology
$60M-1.9%
P/E —·P/S —·Mgn —·ROE —·FCF —
—
50
TILInstil Bio, Inc.
Healthcare · Biotechnology
$54M+2.1%
P/E —·P/S —·Mgn —·ROE -62.7%·FCF —
—
Red 8-K
Filings · filterAll10-K10-Q8-KS-1DEF 14ASC 13D

Filings

40 shown
ESLAWEstrella Immunopharma, Inc.
8-K

Shareholder Vote

Jun 30, 2026·18h ago·Routine
NIMUNON INVASIVE MONITORING SYSTEMS INC /FL/
Companies above the $50M market cap · $1 pricefloor; SPAC/shells hidden by default. Fundamentals & prices via Polygon · signals from SEC EDGAR — verify on SEC.gov. Filings current to Jun 30 · prices to Jun 30.
8-K

Material Agreement

Jun 30, 2026·18h ago·Strategic
GHXIGores Holdings XI, Inc.
8-K

Company Update

Jun 30, 2026·18h ago·Routine
RAINWRain Enhancement Technologies Holdco, Inc.
8-K

Material Agreement

Jun 30, 2026·18h ago·Strategic
CYCUWCycurion, Inc.
8-K

Material Agreement · Reg FD Disclosure

Jun 30, 2026·18h ago·Strategic
ZSQRZ Squared Inc.
8-K

Executive Change · Reg FD Disclosure

Jun 30, 2026·18h ago·Strategic
SWMRSwarmer, Inc
8-K

Material Agreement

Jun 30, 2026·18h ago·Strategic
KAPAKairos Pharma, LTD.
8-K

Shareholder Vote

Jun 30, 2026·18h ago·Routine
BIAFWbioAffinity Technologies, Inc.
8-K

Company Update

Jun 30, 2026·18h ago·Routine
GETYGetty Images Holdings, Inc.
8-K

Company Update

Jun 30, 2026·18h ago·Routine
BANXArrowMark Financial Corp.
8-K

Executive Change

Jun 30, 2026·18h ago·Strategic
BLKBlackRock, Inc.
8-K

Company Update

Jun 30, 2026·18h ago·Routine
DVNDEVON ENERGY CORP/DE
8-K

Shareholder Vote

Jun 30, 2026·18h ago·Routine
NUVBNuvation Bio Inc.
8-K

Material Agreement · Agreement Terminated

Jun 30, 2026·18h ago·Strategic
RCKTWROCKET PHARMACEUTICALS, INC.
8-K

Executive Change

Jun 30, 2026·18h ago·Strategic
JHGJANUS HENDERSON GROUP PLC
8-K

Delisting Notice · Material Agreement

Jun 30, 2026·18h ago·Red Alert
Federal Home Loan Bank of New York
8-K

New Debt / Obligation

Jun 30, 2026·18h ago·Strategic
FOAFinance of America Companies Inc.
8-K

Shareholder Vote

Jun 30, 2026·18h ago·Routine
ACHR-WTArcher Aviation Inc.
8-K

Shareholder Vote

Jun 30, 2026·18h ago·Routine
LMRILumexa Imaging Holdings, Inc.
8-K

Material Agreement · New Debt / Obligation

Jun 30, 2026·18h ago·Strategic
VistaOne, L.P.
8-K

Equity Issuance

Jun 30, 2026·18h ago·Strategic
JUNSJUPITER NEUROSCIENCES, INC.
8-K

Executive Change

Jun 30, 2026·18h ago·Strategic
MUXMcEwen Inc.
8-K

Reg FD Disclosure

Jun 30, 2026·18h ago·Routine
BATLBATTALION OIL CORP
8-K

Auditor Change

Jun 30, 2026·18h ago·Red Alert
VVVVALVOLINE INC
8-K

Material Agreement · New Debt / Obligation

Jun 30, 2026·18h ago·Strategic
Alpex Acquisition Corp
8-K

Company Update

Jun 30, 2026·18h ago·Routine
TLRYTilray Brands, Inc.
8-K

Equity Issuance

Jun 30, 2026·18h ago·Strategic
FWACFuturewave Acquisition Corp
8-K

Material Agreement · Equity Issuance

Jun 30, 2026·18h ago·Strategic
SMXTSolarMax Technology, Inc.
8-K

Delisting Notice

Jun 30, 2026·18h ago·Red Alert
BLNKBlink Charging Co.
8-K

Shareholder Vote

Jun 30, 2026·18h ago·Routine
ALURWALLURION TECHNOLOGIES, INC.
8-K

Executive Change

Jun 30, 2026·18h ago·Strategic
SIGSIGNET JEWELERS LTD
8-K

Shareholder Vote

Jun 30, 2026·18h ago·Routine
CPRXCATALYST PHARMACEUTICALS, INC.
8-K

Company Update

Jun 30, 2026·18h ago·Routine
CEPOCantor Equity Partners I, Inc.
8-K

Company Update

Jun 30, 2026·18h ago·Routine
KRMDKORU Medical Systems, Inc.
8-K

Material Agreement

Jun 30, 2026·18h ago·Strategic
LTCLTC PROPERTIES INC
8-K

Material Agreement · New Debt / Obligation

Jun 30, 2026·18h ago·Strategic
NETCloudflare, Inc.
8-K

Executive Change · Shareholder Vote

Jun 30, 2026·18h ago·Strategic
RNXTRenovoRx, Inc.
8-K

Shareholder Vote

Jun 30, 2026·18h ago·Routine
FFFutureFuel Corp.
8-K

Company Update

Jun 30, 2026·18h ago·Routine
CTGOContango Silver & Gold Inc.
8-K

Material Agreement · Reg FD Disclosure

Jun 29, 2026·1d ago·Strategic